Cargando…
Management of Recurrent Clostridium difficile Infection During Intensive Chemotherapy and Stem Cell Transplantation for Leukemia: Case with Literature Review
Immunocompromised patients undergoing chemotherapy for hematologic malignancy and hematopoietic stem cell transplant (HSCT) recipients are at increased risk of Clostridium difficile (C. difficile) infection (CDI). The recurrence of infection and its associated morbidity and mortality are due to mult...
Autores principales: | Zahid, Umar, Sagar, FNU, Al Mohajer, Mayar, Majeed, Aneela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984265/ https://www.ncbi.nlm.nih.gov/pubmed/29872594 http://dx.doi.org/10.7759/cureus.2413 |
Ejemplares similares
-
Clostridium difficile Infection Complicated by Transformation of Myelodysplastic Syndrome to Acute Myeloid Leukemia With Leukostasis and Sweet’s Syndrome
por: Landry, Ian, et al.
Publicado: (2021) -
Risk for Clostridium difficile Infection After Allogeneic Hematopoietic Cell Transplant Remains Elevated in the Postengraftment Period
por: Dubberke, Erik R., et al.
Publicado: (2017) -
Hemophagocytic Lymphohistiocytosis and Clostridium difficile Infection: A Diagnostic Dilemma
por: Boldig, Kimberly, et al.
Publicado: (2023) -
Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent Clostridium difficile infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials
por: Alhifany, Abdullah A, et al.
Publicado: (2019) -
302. Role of Inflammatory Markers in Diagnosing Diabetic Foot Infection: A Meta-Analysis
por: Majeed, Aneela, et al.
Publicado: (2018)